NDC 55150-270 – Cyclophosphamide
Cyclophosphamide 500 mg/2.5mL · Injection · Intravenous
Product NDC55150-270
Product details
- Brand name
- Cyclophosphamide
- Generic name
- Cyclophosphamide
- Labeler
- Eugia US LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- NDA · NDA210735
- Marketed since
- August 25, 2021
- Listing expires
- December 31, 2026
Active ingredients
- Cyclophosphamide 500 mg/2.5mL
Uses, dosage, side effects and warnings for Cyclophosphamide →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 55150-270-99 | 1 VIAL, MULTI-DOSE in 1 CARTON (55150-270-99) / 2.5 mL in 1 VIAL, MULTI-DOSE | Nov 20, 2023 |
Other Cyclophosphamide products
- 83831-116 Cyclophosphamide 500 mg/mL · Injection · Avyxa Pharma, LLC
- 83831-117 Cyclophosphamide 1 g/2mL · Injection · Avyxa Pharma, LLC
- 83831-118 Cyclophosphamide 2 g/4mL · Injection · Avyxa Pharma, LLC
- 0338-9777 Cyclophosphamide 200 mg/mL · Injection · Baxter Healthcare Company
- 0338-9779 Cyclophosphamide 200 mg/mL · Injection · Baxter Healthcare Company
- 55150-271 Cyclophosphamide 1 g/5mL · Injection · Eugia US LLC
- 55150-272 Cyclophosphamide 2 g/10mL · Injection · Eugia US LLC
- 14789-125 Cyclophosphamide 200 mg/mL · Injection · Nexus Pharmaceuticals, LLC
- 14789-126 Cyclophosphamide 200 mg/mL · Injection · Nexus Pharmaceuticals, LLC
- 62332-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 62332-618 Cyclophosphamide 25 mg/1 · Capsule · Alembic Pharmaceuticals Inc.
- 46708-619 Cyclophosphamide 50 mg/1 · Capsule · Alembic Pharmaceuticals Limited